Jun 29, 2022
Ornithine Decarboxylase (ODC) Inhibitor Pipeline Insight Report 2022 Featuring Orbus Therapeutics, Aminex Therapeutics, Genzyme, Nippon Kayaku, & Cancer Prevention Pharmaceuticals - ResearchAndMarkets.com
Jun 27, 2022
BWXT Medical Executes Commercial Agreement with Bayer for Supply of Actinium-225 Based Products
Jun 22, 2022
Takeda Announces Creation of One Cambridge Campus in Kendall Square to Drive Innovation Efforts
Jun 17, 2022
Camp Lejeune Justice Act Passes, Enabling Reparations for Military, Families and Civilian Who Lived and Worked on Base
Jun 13, 2022
BWXT Medical and TRIUMF Execute Agreement for Manufacture of High Purity Ac-225 Based Products
Jun 08, 2022
The Parker Institute for Cancer Immunotherapy and Resilience Announce Strategic Alliance to Develop Next-Generation Cancer Therapies
Jun 08, 2022
Renewable Sources Now Supplying Over 20% of Promega Global Electricity Use
Jun 08, 2022
StatLab Medical Products acquires CellPath Ltd.
Jun 08, 2022
OrisDX Wins $665K in UChicago’s 2022 New Venture Challenge with Saliva Test to Diagnose Oral Cancers
Jun 03, 2022
Resilience and MD Anderson Launch Joint Venture to Accelerate Development and Manufacturing of Innovative Cell Therapies for Cancer
Jun 02, 2022
Global Sunitinib Malate Market Report to 2027 - Featuring Active Biotech, Astellas Pharma, AstraZeneca and Bristol Myers Squibb Among Others - ResearchAndMarkets.com
May 31, 2022
Fresenius Kabi Introduces New Generic for the Treatment of Non-Squamous Non-Small Cell Lung Cancer
May 27, 2022
2022 Flow Cytometry Life Science Report: A Snapshot of the Current Market Landscape - ResearchAndMarkets.com
May 24, 2022
B dot Medical: Successful Proof of Concept for Ultra-compact Proton Therapy System
May 19, 2022
Be Bio and Resilience Announce Strategic Collaboration to Manufacture Engineered B Cells, a New Class of Cellular Medicines
Apr 29, 2022
BeiGene Breaks Ground on New Manufacturing and Clinical R&D Center at the Princeton West Innovation Campus in New Jersey
Apr 29, 2022
Castle Biosciences Announces Expanded U.S. Federal Supply Schedule Contract Covering Its Entire Dermatologic Cancer Portfolio of Tests
Apr 26, 2022
New Studies Published Comparing BIO 300 to Neulasta® for Acute Radiation Syndrome
Apr 26, 2022
Takeda Recognized as the 2022 ISPE Facility of the Year Awards Winner in Two Categories
Apr 20, 2022
Monopteros Therapeutics Announces Two Presentations at the Tumor Immune Microenvironment Workshop of the Society for Immunotherapy of Cancer (SITC)